The outlook revision is based on a number of factors, including UnityPoint’s more modest operating cash flow margin in fiscal year 2015 and Moody’s Investors Service’s expectation of continued margin pressure.
Moody’s also assigned an “Aa3” rating to UnityPoint’s proposed $46 million of series 2016D bonds and $168 million of series 2016E bonds. The rating assignment reflects UnityPoint’s size, market reach and track record of profitability.
More articles on healthcare finance:
Opponents come out against proposal to charge Ohio Medicaid enrollees
Wyoming hospitals look to cut services as uncompensated care costs rise
Best practices to improve your revenue cycle now: 3 experts weigh in
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
